Cisplatin — Past, Present and Future
Author:
Publisher
Springer US
Link
http://link.springer.com/content/pdf/10.1007/978-1-4613-2837-7_28.pdf
Reference10 articles.
1. Rosenberg B: Cisplatin: its history and possible mechanisms of action in, Prestayko AW, Crooke ST and Carter SK (eds): Cisplatin: Current Status and New Developments; Academic Press, NYC, pp 9–21, 1980.
2. Carter SK and Goldsmith M: The development and clinical testing of new anti-cancer drugs at the National Cancer Institute — example cis-platinum (II) diamminedichloride (NSC 119875) in, Connors TA and Roberts JJ (eds): Platinum Coordination Complexes in Cancer Chemotherapy; Springer-Verlag, Heidelberg, pp 137–145, 1974.
3. Wallace HJ and Higby DJ: Phase 1 evaluation of cis-platinum (II) diamminedichloride (PDD) and a combination of PDD plus Adriamycin. Ibid 2, pp 167-177
4. Higby DJ, Wallace HJ, Albert DJ, et al: Diamminedichlorideplatinum: a Phase 1 study showing responses in testicular and other tumors. Cancer 33:1219, 1974.
5. Wittes RE, Yagoda A, Silvay O, et al: Chemotherapy of germ cell tumors of the testing. Cancer 37: 637, 1976.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Protective effect of bilberry (Vaccinium myrtillus L.) on cisplatin induced ovarian damage in rat;Cytotechnology;2013-08-20
2. Water-soluble Organometallic Analogues of Oxaliplatin with Cytotoxic and Anticlonogenic Activity;ChemMedChem;2010-01-04
3. Liposome Formulations for Effective Administration of Lipophilic Malonatoplatinum(II) Complexes;Japanese Journal of Cancer Research;2002-11
4. Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination;Mutation Research/DNA Repair;2001-06
5. A Phase I study ofcis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies;Cancer;2001
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3